Oncothyreon Inc (USA) (ONTY): Are Hedge Funds Right About This Stock?

Page 1 of 2

Oncothyreon Inc (USA) (NASDAQ:ONTY)Oncothyreon Inc (USA) (NASDAQ:ONTY) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. ONTY shareholders have witnessed a decrease in hedge fund interest recently. There were 10 hedge funds in our database with ONTY positions at the end of the previous quarter.

In today’s marketplace, there are a multitude of indicators market participants can use to track publicly traded companies. Some of the best are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outpace the S&P 500 by a significant amount (see just how much).

Just as key, positive insider trading activity is another way to parse down the marketplace. There are plenty of reasons for an insider to sell shares of his or her company, but just one, very obvious reason why they would behave bullishly. Several empirical studies have demonstrated the impressive potential of this tactic if shareholders know where to look (learn more here).

Now, let’s take a peek at the key action surrounding Oncothyreon Inc (USA) (NASDAQ:ONTY).

How have hedgies been trading Oncothyreon Inc (USA) (NASDAQ:ONTY)?

In preparation for this year, a total of 9 of the hedge funds we track held long positions in this stock, a change of -10% from the previous quarter. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their stakes considerably.

According to our comprehensive database, Andreas Halvorsen’s Viking Global had the biggest position in Oncothyreon Inc (USA) (NASDAQ:ONTY), worth close to $6.5 million, comprising less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Phill Gross and Robert Atchinson of Adage Capital Management, with a $1.8 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other peers that are bullish include Kevin Kotler’s Broadfin Capital, D. E. Shaw’s D E Shaw and Jay Venkatesen’s Ayer Capital Management.

Since Oncothyreon Inc (USA) (NASDAQ:ONTY) has faced falling interest from hedge fund managers, it’s safe to say that there were a few money managers that decided to sell off their positions entirely last quarter. It’s worth mentioning that Jay Venkatesen’s Ayer Capital Management dumped the largest investment of the 450+ funds we key on, worth about $11.3 million in stock., and Samuel Isaly of OrbiMed Advisors was right behind this move, as the fund said goodbye to about $7.8 million worth. These moves are important to note, as total hedge fund interest fell by 1 funds last quarter.

What do corporate executives and insiders think about Oncothyreon Inc (USA) (NASDAQ:ONTY)?

Bullish insider trading is best served when the company in question has experienced transactions within the past 180 days. Over the last six-month time period, Oncothyreon Inc (USA) (NASDAQ:ONTY) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Oncothyreon Inc (USA) (NASDAQ:ONTY). These stocks are Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Cell Therapeutics Inc (NASDAQ:CTIC), NeoStem Inc (NYSEAMEX:NBS), and Biota Pharmaceuticals Inc (NASDAQ:BOTA). This group of stocks are in the biotechnology industry and their market caps are closest to ONTY’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Best States To Practice Medicine

The 10 Best States to Have a Business

The 12 Most Expensive Apple (AAPL) Apps in the Market

The 10 Richest Billionaires in the World

10 Biggest Kickstarter Failures

The 10 Best Places to Work At

The Top 10 of Google Inc (GOOGL)’s Most Expensive Acquisitions

13 Best Cities to Visit in South America

10 Most Expensive Works of Art of All Time

The 10 Richest Banks in the World

The 10 Best-Paying Jobs in America (2014)

7 Most Expensive Foods in the World

The World’s Top 10 Earning Authors

Five Wicked and Very Expensive Items (and Other “Stuff”) Sold on eBay

10 Biggest Celebrity Bankruptcies

The Top 10 Highest Paid CEOs in 2014

The 10 Most Expensive Real Estate Cities in America

10 Most Expensive States To Live In America

The 10 Best Airlines in the World

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!